Cholesterol-lowering drugs called statins have the potential to reduce heart disease in people with obstructive sleep apnea regardless of CPAP use, suggests a new study from Columbia University.
After a sudden medical scare, many people develop a fear of health care and are afraid to adopt new health habits. The Center for Fearless Behavior Change is testing ways to help.
Iok In Christine Chio, PhD, and Oliver Clarke, PhD, early-career investigators at VP&S, are 2023 recipients of prestigious awards from the Irma T. Hirschl Trust Research Scientist Program.
Columbia’s researchers have opened a trial of a noninvasive, focused ultrasound approach to open the blood-brain barrier, enabling higher concentrations of an effective drug to enter the brain.
Columbia will award the 2022 Louisa Gross Horwitz Prize to Karl Deisseroth, Peter Hegemann, and Gero Miesenböck, for research that laid the foundation for the field of optogenetics.
A study of mice found that dietary sugar alters the gut microbiome, setting off a chain of events that leads to metabolic disease, pre-diabetes, and weight gain.
A prenatal test developed by Columbia University researchers can determine if a fetus or embryo has the right number of chromosomes at a fraction of the time, cost of other genetic tests.
Twenty years ago, Columbia scientists created a way to make neurons in a dish, a discovery that has led to clinical trials of an experimental drug that may slow the progression of ALS.
Spontaneous errors in the earliest phase of cell division may explain why so many human embryos fail to develop normally, according to research from Columbia University.